doi:10.1016/j.jpsychires.2018.09.006 Sadeghi O, Keshteli AH, Afshar H, Esmaillzadeh A, Adibi P
After reviewing literature and conducting a two-round Delphi survey with 42 experts, a consensus emerged that emphasizes prioritizing clinical symptoms in diagnosis, with serum B12 as a screening marker supported by methylmalonic acid or homocysteine levels for additional confirmation
Although specific dose recommendations are not available, the clinician should consider a dose reduction of the sulfonylurea or insulin when used in combination with Semaglutide
The additional NSAID and anti-nausea medications will help with pain relief and reduce feelings of nausea
HCG is a potential counter to this
Low levels of B12 can produce symptoms both physical and psychological